<DOC>
	<DOCNO>NCT00749736</DOCNO>
	<brief_summary>Patients chronic kidney disease ( CKD ) commonly deficient vitamin D , low level calcidiol ( 25 hydroxy vitamin D ) calcitriol ( 1,25-hydroxy vitamin D ) . Patients CKD also know abnormality immune cell , increase susceptibility infection increase prevalence malignancy . In patient without kidney disease , repletion vitamin D appear help immune mediated disease . Thus logical patient CKD vitamin D deficient may benefit repletion vitamin D , either native form ( cholecalciferol/ergocalciferol ) form calcitriol analogue . However , interventional data demonstrate repletion positively impact immune status CKD patient . To test hypothesis , large interventional study require . However , prior conduct study , several important step need . The present proposal aim generate necessary data appropriately plan conduct future multi center interventional study . Specifically , examine follow specific aim population CKD stage 3 4 subject Indiana University Affiliated Nephrology Clinics determine 1. abnormality immune cell immune blood test related abnormality vitamin D. 2. reproducible change repeat test 3. repletion vitamin D change cell immune blood test small pilot study .</brief_summary>
	<brief_title>The Role Vitamin D Immune Function Patients With Chronic Kidney Disease ( CKD ) Stages 3 4 .</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>1 alpha-hydroxyergocalciferol</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>administration form vitamin D supplement therapy last 60 day except multi vitamin Hgb &gt; 10 mg/dl able sign inform consent CKD stage 3 ( GFR 3059ml/min ) stage 4 ( GFR 1529ml/min ) iPTH &lt; 70pg/ml stage 3 iPTH &lt; 110pg/ml stage 4 calcidiol level &lt; +20ng/ml initial correct Calcium &gt; 9.7mg/dl initial serum Phosphorus &gt; 5.0mg/dl initial standardize blood pressure &gt; 160/100 history significant liver disease cirrhosis anticipate requirement dialysis 6 month malabsorption , severe chronic diarrhea , ileostomy calcimimetic active vitamin D therapy 60 day prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>vitamin D</keyword>
	<keyword>determine</keyword>
	<keyword>normal</keyword>
	<keyword>intrapatient</keyword>
	<keyword>interpatient</keyword>
	<keyword>variability</keyword>
	<keyword>measure</keyword>
	<keyword>immune system</keyword>
</DOC>